CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Goldman Sachs Initiates Praxis Precision Medicines at Buy With $447 Price Target

Positive
AI Analysis

Summary

Goldman Sachs initiated coverage of Praxis Precision Medicines with a Buy rating and a $447 price target.

Importance:3/10
Sentiment:
0.60
analyst_initiationbuy_ratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 11:37 AM

Read Original